GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » 5-Year Yield-on-Cost %

BioPharma Credit (LSE:BPCR) 5-Year Yield-on-Cost % : 9.45 (As of May. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit 5-Year Yield-on-Cost %?

BioPharma Credit's yield on cost for the quarter that ended in Dec. 2022 was 9.45.


The historical rank and industry rank for BioPharma Credit's 5-Year Yield-on-Cost % or its related term are showing as below:

LSE:BPCR' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 6.19   Med: 8.21   Max: 9.8
Current: 9.45


During the past 7 years, BioPharma Credit's highest Yield on Cost was 9.80. The lowest was 6.19. And the median was 8.21.


LSE:BPCR's 5-Year Yield-on-Cost % is ranked better than
75.31% of 1215 companies
in the Asset Management industry
Industry Median: 5.88 vs LSE:BPCR: 9.45

Competitive Comparison of BioPharma Credit's 5-Year Yield-on-Cost %

For the Asset Management subindustry, BioPharma Credit's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPharma Credit's 5-Year Yield-on-Cost % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's 5-Year Yield-on-Cost % falls into.



BioPharma Credit 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of BioPharma Credit is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

BioPharma Credit  (LSE:BPCR) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


BioPharma Credit 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPharma Credit (LSE:BPCR) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines